KKR is in advanced talks to acquire a majority stake in Medicover Hospitals India in a deal valued at more than $1 billion. The transaction would expand KKR's healthcare platform in India and add a large Indian hospital network to its global private equity portfolio. KKR's stock currently trades around $90.13, having declined 32.4% over the past year and 30.1% year to date, while its three-year return stands at 64.3% and five-year return at 57.3%. The potential acquisition would deepen KKR's exposure to healthcare in a large emerging market and could reshape its sector mix and regional exposure over time.
KKR & Co. Inc.KKR is in advanced talks to acquire a majority stake in Medicover Hospitals India for over $1 billion, expanding its healthcare platform.
Medicover AB Series BMedicover AB's Indian subsidiary is being acquired at a valuation over $1 billion, potentially benefiting the parent company.